Active Shortage

OXALIPLATIN INJECTION, USP

DR REDDY'S LABORATORIES LTD

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of OXALIPLATIN INJECTION, USP in Canada?

Yes. OXALIPLATIN INJECTION, USP 5MG has an active shortage reported to Health Canada (last updated October 27, 2026).

When will OXALIPLATIN INJECTION, USP be available again?

The manufacturer's estimated resolution date is April 22, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file2 products

Expected resolution~5 months remaining (estimate)

Affected strength5MG

Report last updated2026-10-27

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

OXALIPLATIN INJECTION, USP

FRESENIUS KABI CANADA LTD

5MG · DIN 02457423

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

OXALIPLATIN

PFIZER CANADA ULC

5MG · DIN 02444763

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Estimated Resolution

2027-04-22

~5 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02458403

Strength

5MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

OXALIPLATIN

Tier

Unrated

Last Updated

2026-10-27

Reason for Shortage

Other (Please describe in comments)

Source

View original report on healthproductshortages.ca ↗

Other Products from DR REDDY'S LABORATORIES LTD

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

AZACITIDINE FOR INJECTION

100MG · DIN 02462826

BORTEZOMIB FOR INJECTION

3.5MG · DIN 02452456

BORTEZOMIB INJECTION

2.5MG · DIN 02550075

CABAZITAXEL FOR INJECTION

40MG · DIN 02495635

CARBOPROST TROMETHAMINE INJECTION, USP

250MCG · DIN 02530430

DAPTOMYCIN FOR INJECTION

500MG · DIN 02490463